Published on 22/12/2025
Exploring the Types of Wearables Used in Modern Clinical Research
Introduction: The Rise of Wearables in Clinical Trials
Wearable technology has revolutionized modern clinical trials, offering continuous, real-time patient data capture in natural environments. Unlike traditional site visits, wearable devices empower decentralized, patient-centric models that enhance data quality and reduce burden on subjects. From tracking ECGs to detecting sleep disorders, wearables are becoming pivotal in clinical study design and execution.
As per recent FDA guidelines and GxP expectations, wearables used in clinical trials must meet strict validation, calibration, and data integrity standards. This tutorial dives deep into the various categories of wearables commonly adopted in trials, their technical capabilities, and case studies from real-world implementation.
1. Smartwatches and Fitness Bands
Smartwatches like the Apple Watch and Fitbit are widely used in Phase II and III trials to collect continuous data such as:
- ✅ Heart rate variability (HRV)
- ✅ Step count and activity level
- ✅ Sleep duration and quality
- ✅ ECG recordings in newer models (FDA-cleared)
These devices are especially valuable in trials targeting cardiovascular, metabolic, and psychiatric conditions. Their high user acceptance and Bluetooth integration with mobile apps facilitate seamless data transmission to trial platforms.
Example: In a
2. Continuous Glucose Monitors (CGMs)
CGMs such as Dexcom G6 or Abbott’s FreeStyle Libre are highly adopted in diabetes trials. These sensors provide interstitial glucose readings every 5–15 minutes, aiding real-time glycemic control analysis. Benefits include:
- ✅ 24/7 monitoring without finger pricks
- ✅ High patient compliance
- ✅ Granular data on glucose excursions
They are especially useful in crossover trials, adaptive studies, and pediatric populations. CGM data often integrates with mobile apps, enabling real-time alerts for hypoglycemia events.
3. Wearable ECG and Heart Rate Monitors
Clinical-grade ECG patches and monitors such as Zio Patch (iRhythm), Biostrap, or BioBeat are used in cardiac safety and arrhythmia detection studies. These provide:
- ✅ Single or multi-lead ECG
- ✅ Continuous heart rhythm tracking
- ✅ Early detection of QT prolongation or AFib
Such devices are often mandated by sponsors in oncology and CNS trials, where investigational products carry cardiotoxicity risk.
4. Smart Patches and Biosensors
Wearable biosensors include smart patches like VitalPatch (PhysIQ), TempTraq, and MC10 BioStamp. These single-use or reusable sensors adhere to the body and monitor multiple vitals:
- ✅ Skin temperature
- ✅ Respiratory rate
- ✅ Motion or fall detection
- ✅ Posture and activity level
They are frequently used in inpatient studies, oncology trials, and studies involving elderly or high-risk patients. Their passive operation ensures low disruption and high compliance.
5. Pulmonary and Spirometry Wearables
Wearable spirometers like ResApp, NuvoAir, or Microlife devices allow real-time measurement of lung functions such as:
- ✅ FEV1, FVC, PEF parameters
- ✅ Wheeze and cough analysis
- ✅ Nocturnal respiration pattern
These are highly useful in COPD, asthma, and COVID-related research studies. Many are integrated with AI to assist in early diagnosis or endpoint confirmation.
6. Sleep Trackers and Smart Clothing
Advanced devices like Oura Ring, Withings Sleep Analyzer, or Dreem 2 headbands measure:
- ✅ Sleep stages (REM, light, deep)
- ✅ Breathing interruptions
- ✅ HR during sleep cycles
Smart clothing embedded with biosensors (e.g., Hexoskin, Sensoria) collect real-time metrics like respiratory expansion, posture, and ECG in athletes or bedridden patients. Their potential in neurological or fatigue monitoring trials is still under early evaluation.
7. Considerations for GxP Compliance and Validation
All wearable devices in clinical trials must adhere to GxP expectations and undergo thorough validation:
- ✅ Installation Qualification (IQ)
- ✅ Operational Qualification (OQ)
- ✅ Performance Qualification (PQ)
- ✅ FDA 21 CFR Part 11 compatibility for data handling
Also, any device collecting personal data must comply with HIPAA, GDPR, and local DPP (Data Privacy Protection) acts. Auditable logs, backup, and cybersecurity are critical aspects evaluated by QA auditors.
8. Challenges and Real-World Examples
While promising, wearables pose several challenges in trial environments:
- ⚠️ Data Overload: High-frequency data needs robust storage and analytics systems
- ⚠️ Protocol Deviations: Patient non-use or improper wear may skew results
- ⚠️ Connectivity Gaps: Remote sites or rural regions may lack app integration or internet bandwidth
Case Study: A global Phase III insomnia study integrated the Dreem headband for sleep tracking. Though endpoints were achieved, 15% of subjects dropped out due to app syncing issues, highlighting the need for user-centric UI design and field support.
Conclusion
From smartwatches to biosensors and AI-enabled trackers, wearables are redefining data collection in clinical research. Their integration allows for greater decentralization, improved subject experience, and high-fidelity data. However, sponsors must ensure regulatory compliance, robust SOPs, and end-user training to unlock their full potential.